xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

258

International consensus statement on rhinosinusitis

Nyennhuis 194 2020 3 Population-based survey 28,508 patients with asthma Asthma and its comorbidities Patients seen by specialists vs those by primary care physician had more comorbid RS ( p < 0.01). Ostovar 173 2019 3 Cross-sectional,

(Continues)

TABLE V-4 Evidence for asthma as a CRS comorbidity Study Year LOE Study Design Study Groups Clinical Endpoint Conclusions Kaper 193 2020 3 Population-based survey 56,825 adults patients with RS in the Netherlands CRS and its comorbidities 29% had co-morbidities (usually COPD/asthma). Kim 172 2020 3 Population-based survey 14,762 patients with CRS and 29,524 patients without CRS in Korea CRS and its comorbidities The adjusted HR of asthma was 2.06 in CRS vs non-CRS patients.

among the participants

with asthma and there was a significant association

between CRS and current, early and late-onset of asthma.

Asthma was the only factor that was significantly

related to recurrence both in patients with CRSsNP

(HR: 5.54) and in patients

with CRSwNP (HR: 3.27).

phenotype was positively

associated with comorbid asthma.

Comorbid asthma, increased the risk of requiring revision surgery.

CRS was more frequent

An exacerbation-prone

The prevalence of asthma by using the (GA2LEN)

questionnaire and examine its association with CRS

Factors associated with recurrence of CRS

with exacerbations in CRS

Long-term revision rates for ESS

Phillips 30 2019 3 Cross-sectional study Patients with CRS (N = 209) Characteristics associated

5201 patients in the province of Bushehr, Iran completed

the GA2LEN questionnaire

201 patients with CRS who underwent ESS were

followed for an average period of 12 years in a

nonconcurrent cohort.

Smith 189 2019 3 Population-based survey A total of 29,934 patients were identified, with a mean length of follow-up of 9.7 years.

population-based study

Sella 188 2019 3 Nonconcurrent cohort study